Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
In this interview, Jacob C. Jentzer, MD, Assistant Professor of Medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
What are the associations between Takotsubo syndrome and cannabis use? In this Q&A, Rupak Desai, MBBS, explains what he and his research team discovered about the relationship and how their results...
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a...
For patients with advanced heart failure, it is unclear whether outcomes with left ventricular assist device implantation differ by the initial intended goal. A new study investigated these outcomes, and...
Consultant360 spoke with Dr James L Januzzi Jr, who recently co-authored the “2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart...
“Primary care providers are increasingly called upon to recognize and treat heart failure early in their patients”, said Keith C. Ferdinand, MD, during his presentation at CRS 2018, “Update in the...
Dr Jaimin Trivedi and colleagues presented their research at the Heart Rhythm Scientific Sessions 2018 last month. Now, Dr Trivedi is answering our questions about devices in heart failure.
